Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107746861A details a biocatalytic route for high-purity chiral alcohols. Discover cost-effective supply chain solutions for API intermediates.
Advanced synthesis of 2-bromo-1,4-naphthoquinone via novel naphthol bromination. Delivers superior purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN103290078A details enzymatic production of 5-aminovaleric acid. Offers high purity, simplified purification, and scalable bio-based manufacturing solutions.
Patent CN108033899B reveals a safe, ambient-temperature route for Atorvastatin intermediates. Discover cost reduction and supply chain advantages.
Patent CN113979975A details a metal-free chiral phosphoric acid catalyzed kinetic resolution for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Patent CN102911084A details a green synthesis of tert-butyl carbazate using magnetic hydrotalcite catalysts. Achieve high purity and reduced costs in API manufacturing.
Patent CN102911084A details a green synthesis of tert-butyl carbazate using magnetic hydrotalcite catalysts. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturers.
Novel mixed-solvent synthesis for high-purity chiral diamine ruthenium catalysts. Reduces recrystallization needs and boosts yield for asymmetric catalysis applications.
Patent CN1283612C reveals a one-step Friedel-Crafts acylation-esterification process offering high purity and reduced production costs for pharmaceutical intermediates.
Patent CN113735894A discloses a chromium-catalyzed method for synthesizing chiral 2,3-allenols with dual chirality, offering cost reduction in API manufacturing and scalable production.
Patent CN1531523A reveals solvent-free hydrogenation using modifiers for cost-effective diamine manufacturing supply chain optimization and reduced environmental waste disposal burdens significantly.
Patent CN108290910B reveals a stable synthesis route for ruthenium catalyst ligands, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN111848680B reveals a novel bidentate ligand for high-efficiency asymmetric synthesis. Discover cost reduction in API manufacturing and reliable supply chain solutions.
Novel acetone-water solvent system for Boc protection. High yield, low cost, scalable process for pharmaceutical intermediates manufacturing.
Novel decarboxylation route for FGFR inhibitor intermediate offers high yield and purity. Ideal for cost reduction in API manufacturing and scalable supply chains.
Novel synthesis of dihydroxy-2-azabicyclo[2.2.1]heptane-3-carboxylic acid derivatives via Mitsunobu rearrangement. Enhanced solubility and bioavailability for API intermediates.
Patent CN110172048A reveals a scalable synthesis route for 4-vinyl-2(5H)-furanone. Achieve high purity and cost reduction in pharmaceutical intermediate manufacturing with reliable supply.
Patent CN102120749A reveals a novel organocatalyst achieving 99% ee in intramolecular Baylis-Hillman reactions, offering a metal-free route for complex API intermediates.
Patent CN116199572B reveals a novel iron-catalyzed alpha-bromination method offering cost reduction in fine chemical manufacturing and high-purity alpha-bromoketone production.
Patent CN115385948B introduces novel spiro-bisoxazoline ligands offering superior enantioselectivity and simplified synthesis for reliable pharmaceutical intermediates supply chains.